Questions discussed in this category
Based on CheckMate 577?Is DFS endpoint sufficient to establish SOC or is OS benefit needed?
For nodes just inferior to the celiac/SMA axis and no other distant metastatic disease? Stage is formally M1, but just barely. The patient is otherwis...
What combination of fluoropyrimidine, PD-1 inhibitor, or trastuzumab do you use?
KEYNOTE 811 showed improved response rate with the addition of pembrolizumab, but very few patients in this study had low PDL1.
Would you ever consider adjuvant chemotherapy rather than adjuvant immunotherapy after the publication of the CM-577 results? If so, in which pop...
NCCN recommends perioperative FLOT or FOLFOX vs. neoadjuvant chemoRT with Carboplatin/Paclitaxel or FOLFOX.Does CM-577 and the approval of nivolumab p...
What about for a patient with complete radiographic response who declines surgical management?
What factors would influence your approach?
Are there other treatment variations by clinical subsets (eg tumor location, histology, stage II vs III, other biomarkers) seen in CM577 or other data...
Provided the patient can have the solitary met treated definitively with SBRT and is otherwise a good surgical candidate
On occasion, patients with locally advanced gastric cancer are poor candidates for FLOT-like chemotherapy. Should such patients be taken to surgery up...
In a patient with a good performance status, would you consider this?
In a patient with an R0 resection, would you routinely recommend postop chemoradiation, since these patients were included in the MacDo...
7238207141181221212056953238791100211111110011084910443577954495470808826
Papers discussed in this category
Annals of surgical oncology, 2016-11
The Journal of thoracic and cardiovascular surgery, 2007 Aug
Lancet Oncol., 2015-09-01
JAMA oncology, 2018-01-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-07-01
The New England journal of medicine, 2001-09-06
N Engl J Med, 2006 Jul 6
The New England journal of medicine, 2002-10-17
Ann. Surg., 2007-11-01
N Engl J Med, 2021-04-01
J Clin Oncol, 2021 Apr 23
Lancet,
BMC Cancer, 2016 Jul 19
N. Engl. J. Med.,
Lancet, 2012 Jan 07
Lancet, 2018 Jun 04
British journal of cancer, 2011-06-07
JAMA Oncol,
Lancet, 2021 Jun 05
Nature, 2021 Dec 15
Int J Radiat Oncol Biol Phys, 2022 Jul 04